New patent for Alkermes Inc drug LYBALVI

Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are twelve patents…

Source


Comments are closed.

Biotechblog